Hims & Hers Health, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Hims & Hers Health, Inc. announced significant revenue and Adjusted EBITDA growth for 2025, alongside international expansion and new product launches, but faces increasing regulatory and legal challenges.
NYSE
Hims & Hers achieved its first full year of profitability in 2024 and is strategically expanding its capabilities through acquisitions and new specialties.
NYSE
Hims & Hers Health, Inc. announced a significant 65% increase in revenue for 2023, reaching $872 million, fueled by a 48% growth in subscribers and successful expansion into new health and wellness specialties.